• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用2-脱氧-2-[¹⁸F]氟-D-葡萄糖正电子发射断层扫描评估肺癌葡萄糖代谢的常见半定量参数的可重复性。

Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.

作者信息

Nakamoto Yuji, Zasadny Kenneth R, Minn Heikki, Wahl Richard L

机构信息

Division of Nuclear Medicine, Johns-Hopkins University, Baltimore, MD, USA

出版信息

Mol Imaging Biol. 2002 Mar;4(2):171-8. doi: 10.1016/s1536-1632(01)00004-x.

DOI:10.1016/s1536-1632(01)00004-x
PMID:14537140
Abstract

PURPOSE

Positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) has been used for various cancers, but reproducibility of common utilized semi-quantitative parameters, such as the maximal single pixel standardized uptake value (SUV) and effective glycolytic volume (EGV), remains unknown. Knowledge of precision is essential for applying these parameters to treatment monitoring. The purpose of this investigation was to assess the precision of PET results obtained by repeated examinations of patients with untreated lung cancer.

PATIENTS AND METHODS

Ten patients with lung cancer underwent two PET examinations within a week with no intervening treatment. The reproducibility of three parameters:((1) maximal SUV of 1 x 1 pixel anywhere in the tumor, calculated on the basis of predicted lean body mass [SULmax]; (2) highest average SUV at 4 x 4 pixels in the tumor adjusted by predicted lean body mass [SULmean]; and (3) EGV calculated by multiplying SUL by tumor volume), using PET images obtained at 50-60 min post-injection, were examined. Plasma glucose, insulin and free fatty acid levels were also monitored.

RESULTS

The SULmax, SULmean, and EGV were measured with a mean +/- S.D. difference of 11.3% +/- 8.0, 10.1% +/- 8.2, and 10.1% +/- 8.0%, respectively. By multiplying SUL by plasma glucose concentration, the mean differences were slightly reduced to 7.2% +/- 5.8, 6.7% +/- 6.2, and 9.5% +/- 8.2, respectively.

CONCLUSION

These data indicate that commonly used semi-quantitative indices of glucose metabolism on PET show high reproducibly. This supports their use in sequential quantitative analysis in PET, such as in treatment response monitoring.

摘要

目的

正电子发射断层扫描(PET)联合2-脱氧-2-[18F]氟-D-葡萄糖(FDG)已应用于多种癌症,但常用的半定量参数,如最大单像素标准化摄取值(SUV)和有效糖酵解体积(EGV)的可重复性仍不清楚。了解精度对于将这些参数应用于治疗监测至关重要。本研究的目的是评估未经治疗的肺癌患者重复检查获得的PET结果的精度。

患者与方法

10例肺癌患者在一周内接受了两次PET检查,期间无干预治疗。使用注射后50 - 60分钟获得的PET图像,检查三个参数的可重复性:(1)肿瘤内任意位置1×1像素的最大SUV,根据预测瘦体重计算[SULmax];(2)肿瘤内4×4像素的最高平均SUV,经预测瘦体重调整[SULmean];(3)通过将SUL乘以肿瘤体积计算的EGV。同时监测血浆葡萄糖、胰岛素和游离脂肪酸水平。

结果

SULmax、SULmean和EGV测量的平均±标准差差异分别为11.3%±8.0%、10.1%±8.2%和10.1%±8.0%。将SUL乘以血浆葡萄糖浓度后,平均差异分别略有降低至7.2%±5.8%、6.7%±6.2%和9.5%±8.2%。

结论

这些数据表明,PET上常用的葡萄糖代谢半定量指标具有较高的可重复性。这支持了它们在PET的序贯定量分析中的应用,如治疗反应监测。

相似文献

1
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.使用2-脱氧-2-[¹⁸F]氟-D-葡萄糖正电子发射断层扫描评估肺癌葡萄糖代谢的常见半定量参数的可重复性。
Mol Imaging Biol. 2002 Mar;4(2):171-8. doi: 10.1016/s1536-1632(01)00004-x.
2
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
Radiology. 1995 Jul;196(1):167-73. doi: 10.1148/radiology.196.1.7784562.
3
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.在专用全身磁共振/正电子发射断层扫描系统中对肺部病变进行同时采集的弥散加权成像和 2-脱氧-[18F]氟-2-D-葡萄糖正电子发射断层扫描的相关性研究。
Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.
4
Investigation of appropriate semi-quantitative index for assessment of esophageal and breast cancer treatment response in Japanese patients using F-FDG PET/CT findings.利用F-FDG PET/CT检查结果对日本患者食管癌和乳腺癌治疗反应评估的合适半定量指标的研究。
Hell J Nucl Med. 2019 Jan-Apr;22(1):20-24. doi: 10.1967/s002449910955. Epub 2019 Mar 7.
5
The analysis of factors affecting the threshold on repeated 18F-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma.采用PERCIST方案对食管癌患者进行重复18F-FDG-PET/CT检查时影响阈值的因素分析。
Nucl Med Commun. 2012 Nov;33(11):1188-94. doi: 10.1097/MNM.0b013e3283573d0d.
6
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.使用 18F-FDG 和 3'-脱氧-3'-18F-氟胸苷 PET 对晚期非小细胞肺癌厄洛替尼治疗反应的定量分析。
J Nucl Med. 2011 Dec;52(12):1871-7. doi: 10.2967/jnumed.111.094458. Epub 2011 Nov 7.
7
Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.用正电子发射断层扫描(PET)的 2-脱氧-2-[18F]氟-D-葡萄糖对小细胞肺癌患者的预后和疾病进展进行定量评估。
Ann Nucl Med. 2011 Jul;25(6):406-13. doi: 10.1007/s12149-011-0478-y. Epub 2011 Mar 17.
8
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.血糖和体型校正对肺癌患者[18F]FDG PET标准化摄取值的影响。
Eur J Nucl Med. 2001 Jul;28(7):919-22. doi: 10.1007/s002590100561.
9
Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.2-[18F]-氟-2-脱氧-D-葡萄糖和3-脱氧-3-[18F]-氟胸苷正电子发射断层扫描在肺癌成像中的比较
Chin Med J (Engl). 2016 Dec 20;129(24):2926-2935. doi: 10.4103/0366-6999.195468.
10
Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.6-脱氧-6-[18F]氟-D-果糖作为乳腺癌 GLUT5 PET 成像示踪剂的放射药理学评价。
Nucl Med Biol. 2011 May;38(4):461-75. doi: 10.1016/j.nucmedbio.2010.11.004. Epub 2011 Feb 4.

引用本文的文献

1
Focal incidental colorectal fluorodeoxyglucose uptake: Should it be spotlighted?局灶性偶发性结肠氟脱氧葡萄糖摄取:是否应予以关注?
World J Clin Cases. 2024 May 26;12(15):2466-2474. doi: 10.12998/wjcc.v12.i15.2466.
2
Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?主要器官中意外的局灶性氟脱氧葡萄糖摄取;是穿过还是经过?
World J Clin Cases. 2024 Apr 16;12(11):1885-1899. doi: 10.12998/wjcc.v12.i11.1885.
3
Repeatability of F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
乳腺癌患者转移性骨病变中F-FDG摄取的重复性及其对临床试验入组的影响。
EJNMMI Res. 2024 Mar 27;14(1):32. doi: 10.1186/s13550-024-01093-7.
4
Lesion Analysis in PERCIST 1.0: Clinical Ease versus Research Requisite-Where Does the Balance Exist?PERCIST 1.0中的病灶分析:临床便利性与研究必要性——平衡点在哪里?
World J Nucl Med. 2023 Apr 28;22(2):100-107. doi: 10.1055/s-0042-1750406. eCollection 2023 Jun.
5
The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions.甲状旁腺病变中 18F-FCH 摄取强度与细胞含量的关系。
Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2905-2910. doi: 10.1007/s00405-023-07870-9. Epub 2023 Feb 15.
6
Effect of Tumor-Pixel Positioning on the Variability of SUV Measurements in PET Images.肿瘤像素定位对PET图像中SUV测量值变异性的影响。
Asia Ocean J Nucl Med Biol. 2023;11(1):71-81. doi: 10.22038/AOJNMB.2022.61623.1434.
7
Can Radiomics Analyses in F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?原发性乳腺癌的F-FDG PET/CT图像中的放射组学分析能否预测激素受体状态?
Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):49-56. doi: 10.4274/mirt.galenos.2022.59140.
8
lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.长链非编码RNA GAS6-AS1通过抑制E2F1介导的葡萄糖转运蛋白1(GLUT1)转录来抑制肺腺癌的进展和糖代谢重编程。
Mol Ther Nucleic Acids. 2021 May 1;25:11-24. doi: 10.1016/j.omtn.2021.04.022. eCollection 2021 Sep 3.
9
The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.作为一种用于测量癌症治疗反应的成像生物标志物的 FDG PET/CT 的 QIBA 特征。
Radiology. 2020 Mar;294(3):647-657. doi: 10.1148/radiol.2019191882. Epub 2020 Jan 7.
10
Repeatability of [F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients.非小细胞肺癌患者中[F]FDG PET/CT总代谢活性肿瘤体积和总肿瘤负荷的重复性
EJNMMI Res. 2019 Feb 7;9(1):14. doi: 10.1186/s13550-019-0481-1.